Jiangsu Carephar Pharmaceutical Co., Ltd.
3 clinical trials · Sponsor
◉ Watch Jiangsu Carephar Pharmaceutical Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| A Phase II Study of H021 Enteric-coated Tablets for Moderately to Severely Active Crohn's Disease (NCT07677514) | Jiangsu Carephar Pharmaceutical Co., Ltd. | 2026-07-12 |
| A Study of Single and Multiple Ascending Doses of H021 in Healthy Participants (NCT06627556) | Jiangsu Carephar Pharmaceutical Co., Ltd. | 2024-09-17 |
| A Study to Evaluate the Safety, Tolerability and Pharmacokinetics/Pharmacodynamics of Oral Doses of H008 (NCT05050188) | Jiangsu Carephar Pharmaceutical Co., Ltd. | 2021-06-24 |
Track Jiangsu Carephar Pharmaceutical Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.